Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2022-08-11 00:00:00 ET · period of report 2022-08-09 · accession 0001415889-22-008512 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-11 | 2022-08-09 | TBPH | GRAHAM RICHARD A | SVP, DEVELOPMENT | S - Sale | $8.79 | -15.1K | 369.7K | -4% | -$132.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-08-09 | S | D | 15,086 | $8.79 | 369,651 | D | — | — |